This clinical trial tests a community based interventional program, Homeless Women Receiving Onsite Mammography, Patient Navigation and Education (HOPE), in providing breast health services (screening and awareness) to people experiencing homelessness. Preventive screening mammograms improve breast cancer outcomes by detecting cancer when it is at an earlier stage and easier to treat. HOPE may help to remove barriers to breast cancer screening by providing onsite mobile mammograms and patient navigation to people experiencing homelessness.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT04348123.
PRIMARY OBJECTIVE:
I. To evaluate the value and cost savings from the HOPE program.
SECONDARY OBJECTIVES:
I. To assess the true screening rate in our target population with a community-based interventional program approach as compared to the literature.
II. To estimate the baseline mammogram screening rate of our target population prior to enrollment in the program.
III. To identify the unique social barriers to cancer screening and prevention amongst the homeless population and their prevalence and how this intervention changed those barriers for people experiencing homelessness (PEH).
OUTLINE:
Participants complete questionnaire over 10 minutes and may attend an educational session on breast cancer screening. Participants may also undergo mammogram regardless of participation in the education session or the questionnaire. Participants who undergo mammogram are connected with a patient navigator who communicate mammogram results within a week of screening and connect any women needing further breast health services to care.
Trial PhaseNo phase specified
Trial Typescreening
Lead OrganizationCase Comprehensive Cancer Center
Principal InvestigatorHeather Hurwitz
